Avit Gremillion, MD
Ophthalmology · Biloxi, MSNPI 1861479529
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.2% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations.
Across 161 payments — averaging $25.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$888
- Alimera Sciences, Inc.$732
- Regeneron Healthcare Solutions, Inc.$581
- Apellis Pharmaceuticals, Inc.$513
- Sandoz$292
- Amgen$226
- plus $934 from 9 others
What the payments were for
- Food & beverage$4,05297%
- Education$1153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $888 |
| Alimera Sciences, Inc. | 29 | $732 |
| Regeneron Healthcare Solutions, Inc. | 24 | $581 |
| Apellis Pharmaceuticals, Inc. | 17 | $513 |
| Sandoz | 11 | $292 |
| Amgen | 3 | $226 |
| Novartis | 8 | $194 |
| Coherus Oncology, Inc. | 7 | $152 |
| Mallinckrodt Hospital Products Inc. | 3 | $141 |
| Genentech USA, Inc. | 6 | $135 |
| Astellas Pharma US Inc | 5 | $120 |
| ANI Pharmaceuticals, Inc. | 5 | $109 |
| Mallinckrodt Enterprises LLC | 2 | $40 |
| Harrow Eye, LLC | 1 | $29 |
| Eyepoint US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$121
How this compares
$4,166 in reported general payments places this provider in the 75th percentile of 150 ophthalmology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EyleaAflibercept | 200 | $453,479 |
| VabysmoFaricimab-Svoa | 76 | $188,165 |
| SyfovrePegcetacoplan/Pf | 41 | $116,070 |
| Eylea HdAflibercept | 14 | $44,625 |
| IzervayAvacincaptad Pegol Sodium/Pf | 17 | $39,900 |
| LucentisRanibizumab | 21 | $39,794 |
| CimerliRanibizumab-Eqrn | 26 | $33,728 |
| OzurdexDexamethasone | 19 | $26,087 |
| Prednisolone Acetate | 237 | $14,673 |
| Ketorolac Tromethamine | 154 | $4,460 |
| LumiganBimatoprost | 11 | $3,519 |
| CombiganBrimonidine Tartrate/Timolol | 14 | $2,902 |
| Difluprednate | 11 | $2,023 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 53 | $1,148 |
| MoxifloxacinMoxifloxacin Hcl | 32 | $547 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Regeneron Healthcare Solutions, Inc.Eylea, Eylea Hd | $581 | $498,104214 claims |
| Genentech USA, Inc.Vabysmo | $135 | $188,16576 claims |
| Apellis Pharmaceuticals, Inc.Syfovre | $513 | $116,07041 claims |
| Astellas Pharma US IncIzervay | $120 | $39,90017 claims |
| AbbVieOzurdex, Lumigan, Combigan | $888 | $32,50844 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 150 ophthalmology providers in Mississippi.
Other ophthalmology in Biloxi
- Cameron GriffithBiloxi$7K
- Rainna BahadurBiloxi$5K
- Kiper NelsonHattiesburg$234K
- John ParkerTupelo$72K
- Joseph ChildsTupelo$42K
- Heather HancockJackson$39K
- Leslie AdenFlowood$38K
- Adam QuinnHattiesburg$29K
- Mark KoskoJackson$27K
- James ShippOxford$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.